3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Saline Solution
6
Dexmedetomidine
5
Sodium Chloride
4
Temozolomide
3
Sevoflurane
3
Propofol
3
Methotrexate
3
Levetiracetam
3
trametinib
2
perampanel
2
dabrafenib
2
Sugammadex
2
Neuroimaging
2
Methylphenidate
2
Magnetic Resonance Spectroscopy
2
Granulocyte-Macrophage Colony-Stimulating Factor
2
Gentamicins
2
Fluorescein
2
Anesthesia, Inhalation
2
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
pembrolizumab
1
pegvisomant
1
olutasidenib
1
naxitamab
1
lorlatinib
1
gadoterate meglumine
1
gadobenic acid
1
durvalumab
1
dexketoprofen trometamol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Patient-Specific Modeling
×
CNS
×
Clear all
NCT02000739
2014-07-14
GENIUS
Dartmouth-Hitchcock Medical Center
Phase 4
Withdrawn